In targeted radiotherapy (tRT) for lung cancer, IL-17 induces TRT-induced toxicity through inflammation, such as local acute toxicity of RILT, pulmonary fibrosis, pneumonia, etc (10). The gene discussed is IL17A; the disease is susceptibility to pneumonia measurement.